🎯 Drug Targets

IL-1 receptor antagonist or neutralizing monoclonal antibody

Protein-protein interaction modulator or lipid metabolism enhancer

Protein replacement therapy or small molecule mimetic

Protein therapeutics or small molecule mimetics activating Tie2 signaling

Monoclonal antibodies neutralizing TGF-β1 or small molecule inhibitors of TGF-β signaling

CRH receptor antagonist blocking stress hormone signaling

Peptide hormone replacement or stabilization approaches

Modulation of axon guidance and neuronal survival pathways

Recombinant protein replacement or monoclonal antibody modulation

Somatostatin is a peptide neurotransmitter that modulates neuronal signaling by inhibiting hormone release and neuronal excitability, with emerging evidence suggesting its potential neuroprotective role in neurodegenerative processes through regulation of inflammatory responses and synaptic plasticity. In neurodegeneration contexts, SST receptors may serve as modulators of neuroinflammatory cascades and potentially mitigate progressive neuronal damage through receptor-mediated signaling mechanisms.